At a Glance
IndieBio is a venture capital firm based in San Francisco, CA founded in 2014. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Notable portfolio companies include Memphis Meats, Geltor, New Culture, Spiber, Perfect Day, Clara Foods, Zymergen and Bolt Threads. World's largest biotechnology accelerator investing in early-stage startups using biology to solve major global challenges across food, health, materials, and sustainability.
“World's largest biotechnology accelerator investing in early-stage startups using biology to solve major global challenges across food, health, materials, and sustainability.”
IndieBio primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
IndieBio is headquartered in San Francisco, CA. Many of their portfolio companies are also based in this region, though they invest across geographies.
IndieBio focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
IndieBio's typical investment check size ranges from $. to $.. Actual amounts may vary based on the stage, sector, and specific opportunity.
IndieBio manages approximately $250M in assets under management (AUM) across their funds.
